EECP Therapy and Stroke Recovery: Can a Cardiac Treatment Help Grow New Blood Vessels?
When I first heard about EECP therapy in the context of stroke recovery, I was skeptical. It’s a cardiac device approved in Australia for stable angina and congestive heart failure. Stroke is not on the label. So why are we talking about it on a stroke recovery podcast?
Because the mechanism is fascinating. And the research, while still emerging, is pointing somewhere worth paying attention to.
In this episode, I sat down with Jack Clifford, a heart disease patient who discovered EECP therapy and began exploring its potential beyond its approved indications. What started as a cardiac conversation quickly became one of the most scientifically interesting discussions I’ve had on the show.
What Is EECP Therapy?

EECP stands for Enhanced External Counterpulsation. The treatment involves a set of pneumatic cuffs fitted around the calves, thighs, and buttocks. These cuffs inflate and deflate in precise synchrony with the heartbeat, inflating during the heart’s resting phase (diastole) to push blood back toward the heart, and deflating just before the heart contracts.
The result is an increase in blood flow and a specific type of fluid shear stress on blood vessel walls. It’s that shear stress that makes things interesting.
The Biology: Arteriogenesis and Angiogenesis
To understand why EECP therapy might be relevant to stroke survivors, you need to understand two terms: angiogenesis and arteriogenesis.
Angiogenesis is the sprouting of entirely new capillary vessels — the body builds small blood channels where none existed before. Arteriogenesis is different: it’s the remodelling of pre-existing, dormant collateral vessels into functional bypass channels. Think of it like upgrading a dirt track into a highway. The track was always there; the body just wasn’t using it.
When blood flow is obstructed, whether by a blocked coronary artery or a stroke, the body can, under the right conditions, activate these collateral pathways. The shear stress produced by EECP therapy appears to be one of the triggers that stimulate arteriogenesis. By generating repeated waves of increased blood flow, the treatment creates the mechanical signal that tells blood vessel walls to grow and remodel.
This is why cardiac researchers originally developed EECP for heart patients. But it raises a legitimate scientific question: could the same mechanism support blood flow recovery in the brain after stroke?
What Does the Research Say?
A 2026 meta-analysis published in the QJM: An International Journal of Medicine examined 15 randomized controlled trials involving 506 participants, looking specifically at EECP’s effects on functional outcomes in stroke patients. The results showed statistically significant improvements, with EECP outperforming control conditions on standard functional recovery measures.
This is preliminary evidence, not a settled clinical consensus. The studies are relatively small, the methodology varies across trials, and EECP remains off-label for stroke in Australia. But for a therapy with a well-understood safety profile and an existing approval framework, 15 studies and 506 participants is not nothing. It’s enough to warrant serious discussion.
What I Discussed with Jack Clifford
Jack came to EECP as a patient, not a researcher. His experience with heart disease led him to explore the therapy, and he’s spent considerable time understanding the evidence base and connecting with practitioners. He’s not a clinician, and neither am I, but what we can do together is examine what the research actually says, what the mechanism actually is, and what questions remain unanswered.
In our conversation, we discussed:
- How Jack first encountered EECP therapy and what led him to investigate it further
- The difference between approved and off-label use, and why that distinction matters
- What the shear stress mechanism actually looks like in practice
- The existing network of EECP practitioners and how stroke survivors might access the therapy
- The questions both of us still have about where the research needs to go
Important Disclaimers
| ⚠️ EECP therapy is approved in Australia by the TGA for stable angina pectoris and congestive heart failure (ARTG Entry 376470). Stroke is NOT an approved indication. This article and podcast episode are not medical advice. Speak with your treating physician before pursuing any treatment. |
This episode is not medical advice. It is a conversation about an area of emerging research that I find scientifically credible and worth understanding. The goal is to help you ask better questions, not to tell you what treatment to pursue.
Where to Learn More

- ecplocator.com a directory of EECP therapy providers
- eecpbook.com is a dedicated resource on the treatment and its evidence base
- recoveryafterstroke.com for stroke survivors looking for a broader community
Research cited: Zhao et al. (2026). Enhanced external counterpulsation for ischaemic stroke: a systematic review and meta-analysis. QJM: An International Journal of Medicine. DOI: 10.1093/qjmed/hcag010.
Therapy and Stroke Recovery: Can a Cardiac Treatment Help Grow New Blood Vessels?
Bill Gasiamis sits down with Jack Clifford to explore EECP therapy, a TGA-approved cardiac treatment that may stimulate the growth of new blood vessels. Together, they examine the emerging research on angiogenesis, arteriogenesis, and whether this off-label approach holds promise for stroke survivors seeking to improve blood flow to the brain.
Highlights:
00:00 Introduction – EECP Therapy
06:06 Recognizing Health Issues and Seeking Help
09:50 Hospital Experience and Heart Health
12:12 Decisions Against Medical Advice
16:28 Exploring Alternative Treatments
18:06 Understanding Enhanced External Counter Pulsation (EECP)
21:58 The Mechanism of EECP
27:03 Personal Transformation Through EECP
30:29 Lifestyle Changes and Holistic Health
34:35 The Impact of Stress on Health
38:30 The Journey of Writing a Book
43:29 The Role of EECP in Heart Health
48:21 Raising Awareness for EECP Therapy
56:05 Exploring the Future of EECP Therapy



